The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic work-up in patients suspected of pancreatic or periampullary cancer
- PMID: 24650967
- DOI: 10.1016/j.pan.2014.01.001
The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic work-up in patients suspected of pancreatic or periampullary cancer
Abstract
Background: In patients suspected of pancreatic or periampullary cancer, abdominal contrast-enhanced computed tomography (CT) is the standard diagnostic modality. A supplementary endoscopic ultrasonography (EUS) is often performed, although there is only limited evidence of its additional diagnostic value. The aim of the study is to evaluate the additional diagnostic value of EUS over CT in deciding on exploratory laparotomy in patients suspected of pancreatic or periampullary cancer.
Methods: We retrospectively analyzed 86 consecutive patients who routinely underwent CT and EUS before exploratory laparotomy with or without pancreatoduodenectomy for suspected pancreatic or periampullary carcinoma between 2007 and 2010. Primary outcomes were visibility of a mass, resectability on CT/EUS and resection with curative intent.
Results: A mass was visible on CT in 72/86 (84%) patients. In these 72 patients, EUS demonstrated a mass in 64/72 (89%) patients. Resectability was accurately predicted by CT in 65/72 (90%) and by EUS in 58/72 (81%) patients. In 14/86 (16%) patients no mass was seen on CT. EUS showed a mass in 12/14 (86%) of these patients. A malignant lesion was histological proven in 11/12 (92%) of these patients. Overall, resectability was accurately predicted by CT and EUS in 90% (77/86) and 84% (72/86), respectively.
Conclusions: In patients with a visible mass on CT, suspected for pancreatic or periampullary cancer, EUS has no additional diagnostic value, does not influence the decision to perform laparotomy and should therefore not be performed routinely. In patients without a visible mass on CT, EUS is useful to confirm the presence of a tumor.
Keywords: CT; EUS; Pancreatic and periampullary cancer; Preoperative diagnostic assessment.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
-
The value of endoscopic ultrasonography in predicting resectability and margins of resection for periampullary tumors.Am Surg. 2008 Oct;74(10):1026-9. Am Surg. 2008. PMID: 18942637
-
Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: an indirect evaluation of the usefulness of laparoscopy.Pancreatology. 2004;4(5):436-40. doi: 10.1159/000079617. Epub 2004 Jul 6. Pancreatology. 2004. PMID: 15249711
-
Comparison of multislice computed tomography and endoscopic ultrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy.Br J Surg. 2008 Dec;95(12):1512-20. doi: 10.1002/bjs.6330. Br J Surg. 2008. PMID: 18942059
-
Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Jul 6;7(7):CD009323. doi: 10.1002/14651858.CD009323.pub3. Cochrane Database Syst Rev. 2016. PMID: 27383694 Free PMC article. Review.
Cited by
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
-
Impact of prior biliary stenting on diagnostic performance of endoscopic ultrasound for mesenteric vascular staging in patients with head of pancreas and periampullary malignancy.BMJ Open Gastroenterol. 2022 Mar;9(1):e000864. doi: 10.1136/bmjgast-2021-000864. BMJ Open Gastroenterol. 2022. PMID: 35301231 Free PMC article.
-
Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography: a novel approach to predict a periarterial divestment technique in borderline resectable (BR) or locally advanced (LA) pancreatic adenocarcinoma-How I do it.Langenbecks Arch Surg. 2023 Sep 21;408(1):367. doi: 10.1007/s00423-023-03105-x. Langenbecks Arch Surg. 2023. PMID: 37731066 Free PMC article.
-
Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.Eur Radiol. 2017 Aug;27(8):3408-3435. doi: 10.1007/s00330-016-4708-5. Epub 2017 Jan 16. Eur Radiol. 2017. PMID: 28093626 Free PMC article.
-
"Invisible" pancreatic masses identified by EUS by the "ductal cutoff sign".Endosc Ultrasound. 2019 Mar-Apr;8(2):125-128. doi: 10.4103/eus.eus_49_15. Endosc Ultrasound. 2019. PMID: 30880727 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical